Serum levels of immunoglobulin and complement in giant-cell arteritis. 1976

B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig

The levels of IgG, total complement, and complement factors C3 and C4 were elevated in serum from patients with giant-cell arteritis as compared to a control group of patients in the same range of age. No increase of the IgM concentration was found. The concentration of IgA was higher in men with giant-cell arteritis as compared to men in a control group. This increase of IgA was not seen in women. There were no statistically significant differences in any of the studied variables between those with a histologically verified arteritis on temporal biopsy specimens and those without.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig
January 2017, Clinical and experimental rheumatology,
B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig
October 1996, Immunology letters,
B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig
July 1972, Lancet (London, England),
B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig
July 2006, The Journal of rheumatology,
B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig
October 1984, Medicina clinica,
B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig
February 1996, The Journal of rheumatology,
B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig
June 1982, Journal of immunogenetics,
B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig
January 2008, Clinical and experimental rheumatology,
B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig
June 1963, Journal of neurology, neurosurgery, and psychiatry,
B E Malmvall, and B A Bengtsson, and B Kaijser, and L A Nilsson, and K Alestig
October 1971, The British journal of dermatology,
Copied contents to your clipboard!